These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 800236)

  • 1. Clinical trial with rifampicin in the treatment of leprosy.
    Ghosh S; Hazra SK; Kundu S; Choudhury S
    Lepr India; 1976 Oct; 48(4 Suppl):775-80. PubMed ID: 800236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introductory rifampicin therapy in lepromatous leprosy: a six month follow-up study.
    Girdhar BK; Ramu G; Sreevatsa ; Desikan KV
    Lepr India; 1978 Jul; 50(3):363-70. PubMed ID: 359925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial with rifampicin in the treatment of leprosy (final report).
    Ghosh S; Hazra SK; Kundu S; Choudhury S
    Lepr India; 1977 Jul; 49(3):339-43. PubMed ID: 338983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampicin (RFP) trial in lepromatous leprosy.
    Koticha KK; Pade SS; Chulawala RG; Juwatkar PS
    Lepr India; 1982 Jul; 54(3):441-7. PubMed ID: 6757577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Pulsed' rifampicin therapy in leprosy. A clinical study.
    Girdhar BK; Desikan KV
    Lepr India; 1979 Oct; 51(4):475-80. PubMed ID: 392192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
    Reyes-Javier PD; Tantiongco PR
    Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent rifampicin therapy in lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial results of prospective controlled treatment trials in leprosy].
    Pattyn SR
    Verh K Acad Geneeskd Belg; 1984; 46(3):207-19. PubMed ID: 6391013
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifampicin for lepromatous leprosy: nine years' experience.
    Waters MF; Rees RJ; Pearson JM; Laing AB; Helmy HS; Gelber RH
    Br Med J; 1978 Jan; 1(6106):133-6. PubMed ID: 339995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two multidrug regimens in multibacillary leprosy.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and clinical studies on rifampicin in treatment of leprosy.
    Rees RJ; Pearson JM; Waters MF
    Br Med J; 1970 Jan; 1(5688):89-92. PubMed ID: 4903972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse rate and incidence of dapsone resistance in lepromatous leprosy patients in Addis Ababa: risk factors and effect of short-term supplementary treatment.
    Warndorff van Diepen T; Mengistu G
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):189-97. PubMed ID: 2410520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of single dose (1500 mg) rifampicin on infectivity of patients with lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jul; 52(3):359-65. PubMed ID: 7206633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.